<?xml version="1.0" encoding="UTF-8"?>
<p>Despite the lack of clinical trials on TCZ efficacy and safety for COVID-19 treatment, in China TCZ was recently approved for patients affected by severe SARS-CoV-2 pulmonary complications by the National Health Commission of the Peopleâ€™s Republic of China.</p>
